96 related articles for article (PubMed ID: 10869476)
1. Evidence for the involvement of bone morphogenetic protein-2 in phenytoin-stimulated osteocalcin secretion in human bone cells.
Koyama H; Nakade O; Saitoh T; Takuma T; Kaku T
Arch Oral Biol; 2000 Aug; 45(8):647-55. PubMed ID: 10869476
[TBL] [Abstract][Full Text] [Related]
2. Osteogenic actions of phenytoin in human bone cells are mediated in part by TGF-beta 1.
Nakade O; Baylink DJ; Lau KH
J Bone Miner Res; 1996 Dec; 11(12):1880-8. PubMed ID: 8970889
[TBL] [Abstract][Full Text] [Related]
3. Effect of extracellular calcium on the gene expression of bone morphogenetic protein-2 and -4 of normal human bone cells.
Nakade O; Takahashi K; Takuma T; Aoki T; Kaku T
J Bone Miner Metab; 2001; 19(1):13-9. PubMed ID: 11156467
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic protein-2 and -4 (BMP-2 and -4) mediates fraxetin-induced maturation and differentiation in human osteoblast-like cell lines.
Kuo PL; Huang YT; Chang CH; Chang JK
Biol Pharm Bull; 2006 Jan; 29(1):119-24. PubMed ID: 16394523
[TBL] [Abstract][Full Text] [Related]
5. Follistatin restricts bone morphogenetic protein (BMP)-2 action on the differentiation of osteoblasts in fetal rat mandibular cells.
Abe Y; Abe T; Aida Y; Hara Y; Maeda K
J Bone Miner Res; 2004 Aug; 19(8):1302-7. PubMed ID: 15231018
[TBL] [Abstract][Full Text] [Related]
6. Role of activator protein 1 transcriptional activity in the regulation of gene expression by transforming growth factor beta1 and bone morphogenetic protein 2 in ROS 17/2.8 osteoblast-like cells.
Palcy S; Bolivar I; Goltzman D
J Bone Miner Res; 2000 Dec; 15(12):2352-61. PubMed ID: 11127200
[TBL] [Abstract][Full Text] [Related]
7. Piceatannol stimulates osteoblast differentiation that may be mediated by increased bone morphogenetic protein-2 production.
Chang JK; Hsu YL; Teng IC; Kuo PL
Eur J Pharmacol; 2006 Dec; 551(1-3):1-9. PubMed ID: 17026990
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of BMP-2 stimulated adhesion of osteoblastic cells to titanium alloy.
Shah AK; Lazatin J; Sinha RK; Lennox T; Hickok NJ; Tuan RS
Biol Cell; 1999 Mar; 91(2):131-42. PubMed ID: 10399828
[TBL] [Abstract][Full Text] [Related]
10. Participation of endogenous IGF-I and TGF-beta 1 with enamel matrix derivative-stimulated cell growth in human periodontal ligament cells.
Okubo K; Kobayashi M; Takiguchi T; Takada T; Ohazama A; Okamatsu Y; Hasegawa K
J Periodontal Res; 2003 Feb; 38(1):1-9. PubMed ID: 12558931
[TBL] [Abstract][Full Text] [Related]
11. Shedding of a soluble form of BMP receptor-IB controls bone cell responses to BMP.
Singhatanadgit W; Salih V; Olsen I
Bone; 2006 Nov; 39(5):1008-1017. PubMed ID: 16774854
[TBL] [Abstract][Full Text] [Related]
12. Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway.
Hsu YL; Chang JK; Tsai CH; Chien TT; Kuo PL
Biochem Pharmacol; 2007 Feb; 73(4):504-14. PubMed ID: 17113042
[TBL] [Abstract][Full Text] [Related]
13. The effect of bone morphogenetic protein-7 on the expression of type I inositol 1,4,5-trisphosphate receptor in G-292 osteosarcoma cells and primary osteoblast cultures.
Bradford PG; Maglich JM; Ponticelli AS; Kirkwood KL
Arch Oral Biol; 2000 Feb; 45(2):159-66. PubMed ID: 10716620
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
[TBL] [Abstract][Full Text] [Related]
15. Serial passage of MC3T3-E1 cells alters osteoblastic function and responsiveness to transforming growth factor-beta1 and bone morphogenetic protein-2.
Chung CY; Iida-Klein A; Wyatt LE; Rudkin GH; Ishida K; Yamaguchi DT; Miller TA
Biochem Biophys Res Commun; 1999 Nov; 265(1):246-51. PubMed ID: 10548521
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage.
Katagiri T; Yamaguchi A; Komaki M; Abe E; Takahashi N; Ikeda T; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T
J Cell Biol; 1994 Dec; 127(6 Pt 1):1755-66. PubMed ID: 7798324
[TBL] [Abstract][Full Text] [Related]
17. Phenytoin at micromolar concentrations is an osteogenic agent for human-mandible-derived bone cells in vitro.
Nakade O; Baylink DJ; Lau KH
J Dent Res; 1995 Jan; 74(1):331-7. PubMed ID: 7876426
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
[TBL] [Abstract][Full Text] [Related]
19. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2.
Lecanda F; Avioli LV; Cheng SL
J Cell Biochem; 1997 Dec; 67(3):386-96. PubMed ID: 9361193
[TBL] [Abstract][Full Text] [Related]
20. Alphavbeta integrins play an essential role in BMP-2 induction of osteoblast differentiation.
Lai CF; Cheng SL
J Bone Miner Res; 2005 Feb; 20(2):330-40. PubMed ID: 15647827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]